Analysis
| Earnings estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 7 | 6 | 45 | 45 |
| Average estimate | 18.08 | 17.73 | 69.82 | 75.00 |
| Low estimate | 17.60 | 17.10 | 66.90 | 69.80 |
| High estimate | 18.80 | 18.18 | 72.40 | 78 |
| Last year EPS | 16.39 | 16.94 | 64.34 | 69.82 |
| Revenue estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 13 | 10 | 50 | 51 |
| Avg. estimate | 447.44B | 438.65B | 1.76T | 1.87T |
| Low estimate | 436.46B | 420.30B | 1.71T | 1.80T |
| High estimate | 453.18B | 451.21B | 1.80T | 1.92T |
| Last year sales | 417.64B | 409.25B | 1.63T | 1.76T |
| Sales growth | 0.07 | 0.07 | 0.08 | 0.06 |
| EPS trend |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 18.08 | 17.73 | 69.82 | 75.00 |
| 7 days ago | 18.10 | 17.69 | 69.85 | 74.94 |
| 30 days ago | 18.10 | 17.69 | 69.79 | 74.88 |
| 60 days ago | 17.85 | 17.33 | 68.67 | 74.43 |
| 90 days ago | 17.71 | 17.37 | 68.64 | 74.39 |
| EPS revisions |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 2 | 3 | 0 | 0 |
| Up last 30 days | 4 | 5 | 34 | 21 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 2 | 0 | 3 | 14 |
| Growth estimates | |
|---|---|
| Current qtr (Nov 2025) | 0.103% |
| Next qtr. (Feb 2026) | 0.046% |
| Current year (2025) | 0.085% |
| Next 5 years (per annum) | -0.118% |
| Past 5 years (per annum) | -0.436% |
Recommendation
Buy